ASH: A+CHP bests CHOP for peripheral T-cell lymphoma
(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris
Updated on: March 30,2024
19

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma
(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris
Updated on:March 30,2024
19
